urology · men’s health · facts about the prostate
An enlarged prostate does not automatically mean cancer, and an elevated PSA level is not a diagnosis in itself. Equally, the absence of pain or difficulty urinating does not rule out cancer. That is why it is worth separating facts from common misconceptions.
We explain what is known about prostate enlargement and inflammation, cancer risk, sexual health and supplements. We also discuss when to talk to a doctor about testing and which symptoms require prompt medical attention.
Author: Piotr Abbazov, MD
Editor: Jakub Gondek, MD
Published: · Last updated:
The prostate, enlargement, inflammation and cancer — different terms
The prostate, also called the prostate gland, is located below the bladder and surrounds the first part of the urethra. It produces some of the fluid in semen. Having a prostate is not a disease; specific conditions affecting it can cause problems.
| Term | What does it mean? |
|---|---|
| Benign prostatic hyperplasia (BPH) | Non-cancerous enlargement of the gland, which may make urination difficult. |
| Prostatitis and chronic pelvic pain syndrome | Symptoms may include pain, burning and problems during ejaculation. Not every case has a bacterial cause. |
| Prostate cancer | A malignant tumour. Its course and treatment depend on factors including the stage and the characteristics of the cancer cells. |
The symptoms of these conditions can overlap, and some conditions can occur together. A diagnosis cannot be made solely on the basis of frequent urination or the size of the gland. [3], [4], [6]
Myth 1: Prostate cancer only affects older men
Fact: age increases the risk, but being younger does not rule out the disease. Prostate cancer is less common before the age of 50. However, discussing an earlier risk assessment is particularly important if there is a family history or a specific genetic predisposition.
Early prostate cancer often causes no symptoms. Decisions about testing should therefore not depend solely on whether pain or difficulty urinating has developed. [2]
Myth 2: A prostate cancer diagnosis always means a poor prognosis
Fact: not all prostate cancers behave in the same way. Important factors include the stage of the disease, whether it has spread, the PSA level and the aggressiveness of the tumour, assessed through tissue examination using measures such as the Gleason score and ISUP Grade Groups.
Cancer confined to the prostate can often be treated with the aim of achieving a cure. For some patients with low-risk cancer, active surveillance is appropriate: scheduled check-ups and tests instead of immediate surgery or radiotherapy. Advanced disease requires a different treatment approach.
There is no single cure rate that applies to every patient. Surgery and radiotherapy can cause side effects such as erectile dysfunction or urinary problems. Treatment decisions should take account of both the aim of treatment and its potential impact on quality of life. [3]
Survival statistics are not a guarantee of cure. Five-year survival statistics describe a particular group of patients and a defined follow-up period. Without information about the stage of the disease, country and type of measure, a percentage alone can be misleading.
Myth 3: An enlarged prostate means cancer
Fact: benign prostatic hyperplasia is not cancer. It becomes more common with age, but not every man develops symptomatic enlargement requiring treatment. Gland size does not always reflect symptom severity: a large prostate may cause few symptoms, while a smaller one may make urination difficult.
BPH does not rule out cancer occurring at the same time. Getting up at night to urinate, a weak urine stream or a feeling that the bladder has not emptied fully therefore need to be assessed to establish the cause. Management may involve observation, changes to daily habits, medication or a procedure, depending on symptoms and test results. [4]
Myth 4: Frequent sex harms the prostate
Fact: there is no basis for considering the frequency of sex alone a cause of prostate cancer. In an observational study involving more than 31,000 men, more frequent ejaculation was associated with fewer prostate cancer diagnoses, particularly low-risk cancers.
However, this association does not prove that a particular number of ejaculations prevents cancer. Nor does it establish a recommended frequency of sex. Sexual activity does not replace risk assessment or testing agreed with a doctor. [5]
Myth 5: Prostatitis does not affect your sex life
Fact: pain and persistent symptoms can affect sexual function. Symptoms may include painful ejaculation, difficulty getting an erection or reduced sexual desire. These concerns are worth discussing during a consultation.
Treatment depends on the cause. Antibiotics are used for bacterial infections; they are not a universal solution for every type of persistent pain described as “prostatitis”. Chronic pelvic pain syndrome may require a broader approach tailored to the individual. [6]
Myth 6: Genes and family history do not matter
Fact: having a father or brother with prostate cancer increases your risk. The age at diagnosis and the number of affected relatives also matter. Certain inherited gene variants, particularly BRCA2, may justify starting testing earlier.
At your appointment, tell the doctor about cancers in your family and any known genetic test results. Not everyone with a single affected relative needs an immediate genetic panel; the indications are assessed individually. Having no family history does not mean there is no risk. [2], [7]
Myth 7: Zinc and lycopene supplements prevent prostate cancer
Fact: there is no basis for promising this protection. Taking lycopene supplements has not been shown to prevent prostate cancer. Zinc is an essential nutrient, but zinc supplementation is not a proven way to prevent this cancer.
High doses of zinc are not without health risks. In observational studies, long-term supplementation or high doses were associated with a higher risk of aggressive prostate cancer; this alone does not establish cause and effect. A balanced diet matters for overall health, but a “prostate health” supplement does not replace diagnosis or treatment. [7], [9]
When should you talk to a doctor about a PSA test?
According to European Association of Urology guidelines, early PSA testing may be offered to well-informed men:
- from age 50, if there are no additional risk factors,
- from age 45, if there is a family history, particularly a relative diagnosed before age 60, or African ancestry,
- from age 40, for carriers of a pathogenic BRCA2 variant.
The decision takes account of health, life expectancy, previous results and the potential benefits and harms of testing, such as detecting a cancer that would never have caused symptoms. This is not an automatic annual testing schedule for everyone. [2], [10]
If you have symptoms, do not wait until a particular birthday. Investigating symptoms and early detection testing in people without symptoms are different situations.
PSA and prostate symptoms — frequently asked questions
Does an elevated PSA level always mean cancer?
No. PSA can also rise because of benign enlargement or inflammation, and temporarily after certain procedures or activities. The result is interpreted in the context of age, medication, symptoms and previous measurements. The doctor may recommend a repeat test or further investigations. [8]
Does a normal PSA level rule out prostate cancer?
It does not provide that certainty. There is no single PSA value that perfectly separates people with and without the disease. Further management depends on the overall clinical assessment, not simply a result marked “within the normal range”. [8]
Does an abnormal result mean you need an immediate biopsy?
Not always. Depending on the situation, the doctor may first repeat the PSA test, assess the risk or arrange a prostate MRI scan. A biopsy provides tissue for a histopathological diagnosis when there are indications for it. [8]
When should you see a urologist, and when should you seek urgent care?
Reasons to seek a consultation include persistent difficulty urinating, getting up at night to urinate, a weak urine stream, perineal pain, painful ejaculation or abnormal test results. None of these symptoms alone establishes a diagnosis of cancer. [4], [6]
Being unable to pass urine, or having a fever and chills with painful urination, requires urgent medical attention. Visible blood in the urine should not be left to resolve on its own either; prompt medical assessment is needed. [6]
Medical sources and epidemiological data
- Polish National Cancer Registry (KRN), Malignant neoplasms in Poland in 2023 — data on new cancer cases and the distribution of cancers among men.
- European Association of Urology, EAU Guidelines on Prostate Cancer: Diagnostic Evaluation — symptoms, risk assessment, early detection and genetic testing.
- National Cancer Institute, Prostate Cancer Treatment (PDQ), Patient Version — prognostic factors, active surveillance and treatment.
- National Institute of Diabetes and Digestive and Kidney Diseases, Enlarged Prostate (Benign Prostatic Hyperplasia).
- Rider JR et al., Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. European Urology. 2016;70(6):974–982. DOI: 10.1016/j.eururo.2016.03.027.
- National Institute of Diabetes and Digestive and Kidney Diseases, Prostatitis: Inflammation of the Prostate.
- National Cancer Institute, Prostate Cancer Prevention (PDQ), Patient Version — risk factors and evidence concerning lycopene.
- National Cancer Institute, Prostate-Specific Antigen (PSA) Test — interpretation and limitations of the test.
- Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study — an observational study of zinc supplementation.
- Polish National Oncology Portal, Prostate — prevention methods — an individual approach to early detection testing.
Sources accessed: 29 October 2026. KRN figures refer to cases registered in 2023.
This article is for information only and does not replace a medical consultation. The choice of tests, interpretation of results and treatment decisions require an individual assessment.